menu
Showcases Stock ranks

Teva Pharmaceutical Industries Limited (TEVA)
18.46 -0.56 (-2.94%) 12-14 16:01
Open: 18.86 Pre. Close: 19.02
High: 19.16 Low: 18.28
Volume: 9,608,849 Market Cap: 18806M
Share on Facebook   Tweet this page   Tweet this page
Price Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 19.171 - 19.269 19.269 - 19.344
Low: 18.058 - 18.158 18.158 - 18.235
Close: 18.301 - 18.469 18.469 - 18.598
Stock Technical Analysis
Overall:     
Target: Six months: 25.62
One year: 28.58
Support: Support1: 17.83
Support2: 14.83
Resistance: Resistance1: 21.93
Resistance2: 24.47
Pivot: 20.41
Moving Averages: MA(5): 18.68
MA(20): 20.84
MA(100): 22.16
MA(250): 21.03
MACD: MACD(12,26): -0.91
Signal(12,26,9): -0.60
%K %D: %K(14,3): 14.96
%D(3): 14.16
RSI: RSI(14): 27.56
52-Week: High: 25.96
Low: 16.35
Change(%): -0.8
Average Vol(K): 3-Month: 1114791
10-Days: 1237635
Price, MAs and Bollinger Bands
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.

TEVA has closed above bottom band by 15.3%. Bollinger Bands are 49.7% wider than normal. The large width of the bands suggest high volatility as compared to TEVA's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.
Stock chart
Stock News
2018-12-15T09:12:29-05:00
Stocks To Watch: Time To Connect The Dots

Financial Analysis
Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 1018.73
Shares Float (M) 1016.31
% Held by Insiders 0.20
% Held by Institutions 110.20
Shares Short (K) 34763
Shares Short Prior Month (K)
Stock Financials
EPS 3.210
EPS Est. Current Year 4.230
EPS Est. Next Year 3.690
EPS Est. Next Quarter 1.090
Forward EPS 2.790
Book Value (p.s.) 1.480
PEG Ratio -0.94
Profit Margin -57.30
Operating Margin 16.32
Return on Assets (ttm) -14.6
Return on Equity (ttm) -52.0
Qtrly Rev. Growth -19.4
Gross Profit (p.s.) 2.495
Sales Per Share
EBITDA (p.s.) -12.279
Qtrly Earnings Growth
Operating Cash Flow (M) 4220.00
Levered Free Cash Flow (M) 4360.00
Stock Valuation
P/E 5.75
P/E Growth Ratio -0.03
P/BV 12.47
P/S 973085184.00
P/CF 4.46
Dividend Yield
Dividends & Splits
Dividend
Dividend Pay Date 2017-12-12
Ex-Dividend Date 2017-11-27
Forward Dividend
Last Split Date
Last Split Ratio -1e+010

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator